Telix
Telix Pharmaceuticals Ltd
Quick answer
Telix is a pharma company (TLX) headquartered in NORTH MELBOURNE, C3, USA with 24 tracked pipeline programs.
Pipeline (24)
177Lu-TLX250
ccRCC
1 trials project177Lu-TLX591
Metastatic Castration-resistant Prostate Cancer
1 trials project68Ga-PSMA-11
PCA
1 trials project89Zr-Girentuximab
Clear Cell Renal Cell Carcinoma
2 trials project89Zr-TLX250 PET/CT
Clear Cell Renal Cell Carcinoma
1 trials projectGa-68-PSMA-11
Prostate Cancer
1 trials projectStandard of Care
Metastatic Prostate Cancer
1 trials projectTLX-101-Tx + Lomustine
Neoplastic Disease
1 trials project177Lu girentuximab
Advanced Cancer
1 trials project177Lu-DOTA-TLX591
Prostate Cancer
1 trials project4-L-[131I]iodo-phenylalanine (131I-IPA)
Glioblastoma Multiforme
1 trials project89Zr-Girentuximab
Clear Cell Renal Cell Carcinoma (ccRCC)
1 trials project89Zr-girentuximab for PET/CT imaging of CAIX positive tumors
Cervical Cancer
1 trials projectFluciclovine F18
Prostate Adenocarcinoma
1 trials projectPSMA PET/MR - Gallium-68 labeled PSMA-HBED-CC
Prostate Cancer
1 trials projectZirconium Zr 89 Girentuximab
Clear Cell Renal Cell Carcinoma
1 trials project131I-IPA
Neoplastic Disease
1 trials project153Sm-DOTMP
Bone Pain
1 trials project177Lu-DOTA-TLX591
Metastatic Prostate Cancer
1 trials project177Lu-TLX250 and Peposertib
Solid Tumor, Adult
1 trials project64Cu-DOTA-TLX592
Metastatic Prostate Cancer
1 trials project68-Ga PSMA11
Prostate Adenocarcinoma
1 trials project89Zr-DFOsq-olaratumab (89Zr-TLX300-CDx)
Soft Tissue Sarcoma
1 trials project89Zr-Girentuximab
Clear Cell Renal Carcinoma
1 trials